1GATES M, TSCHUDI G. The Synthesis of Morphine[ J ]. J Am Chem Soc, 1956, 78(7): 1380-1393.
2STANLEY T H. The history and development of the fentanyl series [J]. J Pain Symptom Manage, 1992, 7(3 Suppl) : S3 -S7.
3ROSOW C. Remifentanil: a unique opioid analgesic[J]. Anes- thesiology, 1993, 79(5) : 875 -876.
4SNYDER G L, GREENBERG S. Effect of anaesthetic technique and other perioperative factors on cancer recurrence[ J]. Br J An- aesth, 2010, 105(2): 106-115.
5YEAGER M P, COLACCHIO T A, YU C T, et al. Morphine in- hibits spontaneous and cytokine - enhanced natural killer cell cyto- toxicity in volunteem[ J]. Anesthesiology, 1995, 83 ( 3 ) : 500 - 508.
6SACERDOTE P, BIANCHI M, GASPANI L, et al. The effects of tranladol and morphine on immune responses and pain after surgery in cancer patients [ J]. Anesth Analg, 2000, 90 (6) : 1411 - 1414.
7BEILIN B, SHAV1T Y, HART J, et al. Effects of anesthesia based on large versus small doses of fentanyl on natural killer cell cytotoxicity in the perioperative period[J]. Anesth Analg, 1996, 82 (3) : 492 - 497.
8AFSHARIMANI B, CABOT P, PARAT M O. Morphine and tumor growth and metastasis[J]. Cancer Metastasis Rev, 2011,30(2) : 225 - 238.
9LENNON F E, MIRZAPOIAZOVA T, MAMBETSARIEV B, et al. The Mu opioid receptor promotes opioid and growth factor - in- duced proliferation, migration and Epithelial Mesenchymal Transi- tion(EMT) in human lung cancer[J]. PLoS One, 2014, 9(3) : e91577.
10YEAGER M P, ROSENKRANZ K M. Cancer recurrence after sur- gery: a role for regional anesthesia? [ J]. Reg Anesth Pain Med, 2010, 35(6) : 483 -484.
